We’re building the first universal virtual cell-signaling model to decode the language of cells—so biology is no longer destiny, but design.
Joined December 2023
- Tweets 134
- Following 23
- Followers 960
- Likes 92
74 Photos and videos
Pinned Tweet
Today we’re sharing a defining moment for Cellular Intelligence.
We have entered into an agreement with @novonordisk to acquire STEM-PD, a Phase 2-ready allogeneic cell therapy program for Parkinson’s disease. Alongside the acquisition, Novo Nordisk is making a strategic investment in Cellular Intelligence.
This is one of the most advanced cell therapy programs in Parkinson’s. The program has an FDA-cleared IND for Phase 2 and Fast Track Designation, following completion of Phase 1/2 dosing in the underlying academic clinical program, STEM-PD.
This is more than an asset acquisition.
It marks the beginning of an AI-native era for cell replacement therapy.
One where biology is no longer destiny, but design.
Read all about it here: cellularintelligence.com/ste…
#CellTherapy #ParkinsonsDisease #Biotech #AIinBiotech #TechBio
STEM-PD is an investigational therapy; its safety and efficacy have not been established.
2
18
1,195
How is AI-bio moving from concept to clinical-stage impact?
Cellular Intelligence CEO @MichaBreakstone sat down with @CNBC 's @jonfortt to discuss how we're turning biology into a predictive engineering discipline.
Cell signaling is a language. Just as foundation models learned to predict ours, we're learning to predict theirs. When we get that right, we step into the era of programmable biology.
🎬 Watch the full conversation here: cnbc.com/video/2026/06/09/mi…
1
121
What is the future of AI x Bio?
Yesterday in Copenhagen, we set out to answer exactly that. At the @novonordiskfond headquarters, we convened leaders across AI, biology, regenerative medicine, venture, and company building for a day-long symposium on Engineering Cell Fate—and what we believe will become the next AlphaFold moment for biology. 🧵
3
2
9
633
Keynote & Speakers:
Mads Krogsgaard Thomsen, @nasdaily, @MatttBuckley, Thomas Carlsen, @StephanChr25527, @andreascleve, @johncumbers, @VitalayFomin, Gunner Laine Hardy, @kim_bak_jensen, Petrina Kamya, @Kirkeby_Lab, @MatLegut, @aijamayrock, @jb_michel, Jens Nielsen, @ParmarLab , Travis Potter, Tali Raveh, @ArmonSharei, @ReshefShilon, @NTallapragada, @aloktayi, @VallierLab, @PeterAksel
1
141
Founders & Leadership Team:
@MichaBreakstone, Olivier Pourquie, @JShendure, @arjunrajlab, @KleinLabHMS, Cliff Tabin, @TweetKJBrown, Tzvika Cohen, @SamanthaDStrass, Nuno Mendonça, Marianne Stemann Andersen.
1
83
This week at the @KeystoneSymp on Computational Advances in Drug Discovery, our VP of Strategy @SamanthaDStrass gave a spotlight talk, and @baagmery, Principal Scientist in Computational Biology, presented on the poster floor — joining the conversation at the frontier of computational drug discovery.
Their talk and poster showcased our multiplexed platform and its ability to generate data at unprecedented scale — the foundation for our work toward a Universal Virtual Cell-Signaling Model that predicts context-dependent signaling response and, ultimately, controls cell fate. This unlocks a range of applications: iPSC-based disease modeling, drug response prediction, target identification, and protocol design for cell therapies.
These capabilities turn biology from a trial-and-error science into predictive engineering.
Thank you to Keystone Symposia for the opportunity to share our work. We're building a future where biology is no longer destiny, but design.
#ksdrugdiscovery2026
@arjunrajlab, Kristy Brown, @KleinLabHMS, Olivier Pourquié
3
8
1,971
Today, our CEO @MichaBreakstone joined a brilliant panel alongside @iamjohnnyyu from @tahoe_ai and @glebkuz from @ManifoldBio—masterfully moderated by @FabioZB_I of Polyphron—to answer a pivotal question: Why now? 🧵
1
5
303
By capturing this scale, we can look at biology not as static states, but as dynamic transitions. We are moving away from empirical trial-and-error to essentially learning the grammar of cellular decision-making, which fundamentally transforms how we can engineer cell therapies and model disease.
1
130
We are incredibly energized by the breakthroughs happening alongside us, and believe that as we learn causal cellular grammar, we are building a future where biology is no longer destiny, but design.
89
Our CEO @MichaBreakstone just stepped off the stage at #SynBioBeta2026. The energy in the room was electric, confirming what we've believed since day one at Cellular Intelligence: Biology is ready to be transformed from trial-and-error into a true engineering discipline.
Thank you @SynBioBeta for the platform to share our vision. We are building a future where biology is no longer destiny, but design.
2
13
688
In just one hour at #SynBioBeta2026, our CEO @MichaBreakstone takes the stage to outline the future of cellular engineering.
Join us. We are building a future where biology is no longer destiny, but design.
Thanks @SynBioBeta for the stage.
3
7
482